Lv62
2080 积分 2024-09-29 加入
Chemotherapy-Induced Nausea and Vomiting
6天前
已完结
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
10天前
已完结
Primary tumor surgery in patients with de novo stage IV breast cancer: Is there an optimal subgroup for locoregional therapy?
12天前
已完结
Novel Pharmacological Approaches to Target Mitochondrial Metabolism and DNA Damage Response in Colorectal Cancer and their Synergism with Established Chemotherapeutics
24天前
已完结
HER2-positive breast cancer
1个月前
已完结
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
1个月前
已完结
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
1个月前
已完结
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
1个月前
已完结
A Review of Current and Future Antibody Drug Conjugates in Breast Cancer
1个月前
已完结
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
